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Abstract 
In recent years, there has been a significant increase in pediatric onset of type II diabetes. 
This paper will examine elements contributing to this trend. Type II diabetes will be 
discussed, including related pathophysiology, manifestations, diagnosis, and 
complications, with differentiation between adult and pediatric onset. Possible prevention 
and treatment methods appropriate for pediatric patients will also be discussed, along 
with possible outcomes in pediatric patients that could result from this disease. Overall, 
this paper will provide insight on the causes of this growing trend, and ways to improve 
the risks imposed on pediatric patients.  
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Pediatric Type II Diabetes: Examining the Upward Trend 
Since the mid-1990s, the rate of pediatric type II diabetes has been on the rise. 
Between the years of 2001 and 2009, the incidence of type II diabetes among pediatric 
patients increased by over 30% (Laffel & Svoren, 2017a). Currently, according to the 
American Diabetes Association, the incidence of this disease among children is expected 
to increase annually by 2.3%, and quadruple within the span of 40 years (American 
Diabetes Association, 2018). While normally diagnosed in adulthood, this disease is 
becoming diagnosed more commonly in children and adolescents. In order to gain a full 
understanding of this phenomenon, the pathophysiology, manifestations, diagnosis, and 
complications of type II diabetes mellitus will first be discussed, comparing adult and 
pediatric onset.  Secondly, research will be examined to identify any factors that could be 
causing this upward trend, including risk factors and genetic predispositions. Lastly, 
current treatments and outcomes among this patient population will be discussed. Lastly, 
current treatments and outcomes among this patient population will be discussed, 
providing more insight on the increasing trend of pediatric type II diabetes mellitus and 
how to decrease its incidence. 
Pathophysiology 
Diabetes mellitus, commonly referred to as diabetes, is a disease process that 
interferes with glucose metabolism and regulation. It is often characterized by elevated 
blood glucose levels, known as hyperglycemia. Glucose is a product of food metabolism, 
broken down from carbohydrates that are consumed. When it is produced, insulin drives 
glucose molecules to dissolve into blood plasma, transporting glucose throughout the 
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body to be used for energy production. In a healthy body, pancreatic beta cells naturally 
produce insulin at a rate to match blood glucose levels. With proper regulation, blood 
glucose levels are normally between 70 and 120 mg/dL. Insulin also helps to maintain 
blood glucose levels by encouraging the storage of glucose in the liver as glycogen, and 
inhibits the production of more glucose, known as gluconeogenesis. However, with 
diabetes mellitus, beta cell dysfunction or insulin resistance have occurred, which 
disrupts the normal regulation of glucose metabolism (Lewis, Dirksen, Heitkemper, 
Bucher, & Harding, 2015).  
While multiple forms of diabetes mellitus exist, the primary forms are classified 
as type I or type II diabetes mellitus. The primary difference between the two types is the 
cause of the disease and sometimes, its severity. Type I diabetes mellitus is primarily 
linked to autoimmune effects, in which the body’s immune system attacks the beta cells. 
Ultimately, this results in beta cell dysfunction and a complete lack of insulin production. 
While this can occur in adults, this type of diabetes is most commonly seen in children. 
Therefore, it was commonly known as juvenile diabetes (Grossman & Porth, 2014). 
However, type II diabetes is becoming more common in children. Research by Pulgaron 
and Delamater (2015) supports this, finding that since the mid-1990s, the percentage of 
pediatric diabetic cases with type II has increased from 1-2% to 25-45%.  
Unlike type I diabetes, type II diabetes does not involve complete beta cell 
dysfunction with lack of insulin production. Instead, a wide range of insulin production 
exists for type II diabetics. In fact, some type II diabetics may be able to produce large 
amounts of insulin. Therefore, one of the biggest problems with type II diabetics is not 
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insulin production, but insulin resistance (Grossman & Porth, 2014, p. 1311). Insulin 
resistance occurs as tissues throughout the body develop a higher difficulty in absorbing 
blood glucose. In order to compensate for this, beta cell production increases, providing 
more insulin in order to foster glucose absorption. However, with time, this increased 
strain on beta cells can cause dysfunction. This decreases insulin production and glucose 
levels in the bloodstream begin to rise. As previously mentioned, insulin plays a role in 
inhibiting gluconeogenesis from the liver. However, with decrease insulin production, the 
liver continues to break down glycogen, and contributes to further increases in blood 
glucose levels. Ultimately, these processes contribute to the hyperglycemia that 
accompanies type II diabetes mellitus (Lewis et al., 2015). 
Hyperglycemia can result in a variety of manifestations that often accompany 
type II diabetes. One of these manifestations is polyuria, or excessive urination. The 
kidneys play a role in fluid and electrolyte regulation, which is disturbed with 
hyperglycemia. Normally, the glomeruli of the kidneys filter out different molecules from 
the blood, such as urea, sodium, and glucose. Then, the renal tubules reabsorb the proper 
amount of these substances needed for the body’s needs. The rest of the waste is 
eliminated through the urine. Since glucose levels are in excess with type II diabetes, the 
kidneys will attempt to eliminate glucose rather than reabsorb it.  This results in 
glycosuria, or the presence of glucose in the urine. Additionally, due to the principles of 
osmosis, increasing glucose concentration in the urine promotes the movement of fluid of 
water from inside cells to the urine. As more fluid leaves the cells, dehydration occurs. 
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This intracellular dehydration contributes to another common symptom of type II 
diabetes, polydipsia (Grossman & Porth, 2014, p. 1314). 
Manifestations 
Hyperglycemia can result in a variety of manifestations that often accompany 
type II diabetes. One of these manifestations is polyuria, or excessive urination. The 
kidneys play a role in fluid and electrolyte regulation, which is disturbed with 
hyperglycemia. Normally, the glomeruli of the kidneys filter out different molecules from 
the blood, such as urea, sodium, and glucose. Then, the renal tubules reabsorb the proper 
amount of these substances needed for the body’s needs. The rest of the waste is 
eliminated through the urine. Since glucose levels are in excess with type II diabetes, the 
kidneys will attempt to eliminate glucose rather than reabsorb it.  This results in 
glycosuria, or the presence of glucose in the urine. Additionally, due to the principles of 
osmosis, increasing glucose concentration in the urine promotes the movement of fluid of 
water from inside cells to the urine. As more fluid leaves the cells, dehydration occurs. 
This intracellular dehydration contributes to another common symptom of type II 
diabetes, polydipsia (Grossman & Porth, 2014, p. 1314). 
 Manifestations for type II diabetes mellitus usually appear slowly, over time. As 
previously discussed, some of the manifestations of type II diabetes mellitus include 
polyuria and polydipsia. However, there is a large variety of symptoms that could be 
present with type II diabetes. Due to the combination of beta cell dysfunction and insulin 
resistance, less glucose is being received by tissues throughout the body. This contributes 
to feelings of and excessive hunger (polyphagia) that can be experienced by patients. 
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Additionally, patients may experience weight loss, blurred vision, frequent infections, 
and areas of darkened skin, known as acanthosis nigricans (Mayo Clinic Staff, 2018).  
Many of these manifestations appear within the pediatric population. Between 57 and 70 
percent of cases present with symptomology, including polyuria, polydipsia, and 
nocturia. Additionally, adolescent girls may present with complaints of a yeast infection, 
which could be a sign of hyperglycemia (Laffel & Svoren, 2017a).  
Some pediatric patients may even present with serious hyperglycemic conditions, 
such as diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS). DKA 
is more common in patients with type I diabetes, but can still occur in type II patients. In 
fact, 5 to 10 percent of pediatric patients may present with DKA (Lassel & Svoren, 
2017a). With type II diabetes, it becomes more difficult for the body to use glucose as an 
energy resource, despite high amounts being available. If tissues are not receiving enough 
glucose, another source of energy is found through fats and proteins. Cells from adipose 
tissue release lipase, which releases fatty acids to be used as energy. However, these fatty 
acids contribute to ketone production by the liver, which contributes to acid production in 
the blood. As ketones begin to build up in the blood, the kidneys begin to excrete them, 
causing ketonuria. Additionally, muscles are broken down to form amino acids, which 
can be used as a source of energy. This results gluconeogenesis in the liver, which 
worsens the hyperglycemia. Ultimately, the body’s compensation mechanisms for 
hyperglycemia can often worsen the condition, resulting in acidosis and ketonuria. These 
factors contribute to a diagnosis of DKA, which can ultimately result in circulatory 
collapse without treatment (Grossman & Porth, 2014).   
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While not as common in the pediatric population, it is possible for a patient to 
present with HHS. Unlike DKA, this condition does not involve ketonuria, but instead 
involves a more severe shift of fluid and electrolytes. High glucose levels of 600 mg/dL 
or higher cause a shift of fluid out of the cells, causing severe dehydration. Without 
proper treatment, this condition is highly fatal for pediatric patients (Laffel & Svoren, 
2017a).  
Diagnosis 
 Diagnosis of type II diabetes can be done by recognizing signs and symptoms, 
monitoring risk factors, and performing diagnostic tests. Noting symptoms such as 
polyuria and polydipsia are important to recognize the need for further diagnostic testing. 
However, as previously discussed, many patients may present as asymptomatic. 
Therefore, it is necessary for healthcare providers to monitor for possible risk factors. 
Pediatric risk factors may include a family history of type II diabetes, being part of a 
high-risk ethnic group, maternal history of diabetes during gestation, hypertension, 
dyslipidemia and polycystic ovary syndrome. Patients with a BMI above 85th percentile, 
having at least two of these risk factors, should be monitored beginning at the age of 10, 
and every three years following, according to the American Diabetes Association (Laffel 
& Svoren, 2017).  
These pediatric patients, as well as adults with presenting risk factors, can be 
diagnosed with the use of three laboratory tests. One of these tests is the hemoglobin A1C 
test. This test allows healthcare providers to evaluate the patient’s average glucose levels 
for the past 3 months. If the patient’s A1C score is between 5.7 and 6.4, the patient is 
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considered to have “prediabetes”. This result indicates the patient is at high risk for 
developing type II diabetes in the future (National Institute of Diabetes and Digestive and 
Kidney Disease, 2017).  Screening tests, such as the hemoglobin A1C, have been shown 
to effectively diagnose pediatric patients with prediabetes (Laffel & Svoren, 2017a). If 
the patient’s score is 6.5 or above, the patient can have a definite diagnosis of type II 
diabetes. Another laboratory test performed is the fasting plasma glucose (FPG) test. The 
patient must be fasting for at least 8 hours, then their blood glucose level is measured. 
Type II diabetes can be diagnosed with a blood glucose level of 126 mg/dL or above, 
while normal levels would be considered below 100 mg/dL. Lastly, the third test used for 
diagnosis is the oral glucose tolerance test (OGTT). The patient must be fasting for at 
least 8 hours, then the patient consumes a sugary liquid. If after two hours, the patient’s 
glucose is over 200 mg/dL, then the patient can be given a diagnosis of type II diabetes 
(National Institute of Diabetes and Digestive and Kidney Disease, 2017).  
Complications 
 Patients diagnosed with type II diabetes are at risk for a variety of short-term and 
long-term complications. Short-term complications may be related to fluctuating glucose 
levels, such as hypoglycemia. Some patients with type II diabetes can receive 
supplemental insulin, which normalizes glucose levels by driving blood glucose into the 
cells. However, if the wrong amount of insulin is given, too much of the blood glucose 
will be removed from the bloodstream, causing low levels of blood glucose, also known 
as hypoglycemia. Hypoglycemia is characterized by a blood glucose levels below 70 
mg/dL (Lewis et al., 2015, p. 1179). Hypoglycemia can cause patients to experience 
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tachycardia and diaphoresis. Without proper administration of glucose, whether through 
artificial means or food consumption, the patient is at risk for loss of consciousness or 
even death. Therefore, while type II diabetes is characterized by hyperglycemia, 
hypoglycemia can be even more dangerous for the patient (Burchum, Rosenthal, Jones, 
Neumiller, & Lehne, 2016, p. 9). 
 Despite the possibility of hypoglycemia, hyperglycemia contributes to a majority 
of type II diabetes complications. The accumulation of blood glucose molecules for 
prolonged time periods causes damage to blood vessels throughout the body. These 
complications are organized into two categories: microvascular and macrovascular 
complications (Amutha & Mohan, 2016). 
Microvascular Complications 
 Microvascular complications affect the smaller blood vessels across the body. 
Damage most often occurs in areas such as the eyes, microvascular complication of 
significance is diabetic retinopathy. This condition occurs when high glucose levels affect 
the blood vessels supplying the retina, which aids in normal vision. Ultimately, with 
persisting damage from hyperglycemia, diabetic retinopathy can result in blindness. 
According to Tryggestad and Willi, diabetic retinopathy is “the leading cause of 
blindness in Americans aged 20-74” (2015, p. 310). However, mixed reports have been 
found within pediatric cases. A study performed by Dart, Martens, Rigatto, Brownell, 
Dean, and Sellers compared pediatric type II diabetes, type I diabetes, and non-diabetic 
patients. The results of this study suggest that pediatric patients with type II diabetes were 
at a lower risk for retinopathy than their adult and type I diabetic counterparts (2014). 
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Meanwhile, Mayer-Davis and other researchers of the SEARCH study reported that 42 
percent of pediatric patients with type II diabetes were diagnosed with diabetic 
retinopathy after at least 5 years of duration (Amutha & Mohan, 2016). Either way, risk 
of blindness should be a consideration for all pediatric type II diabetes patients. 
   Another microvascular complication includes diabetic nephropathy. As 
previously mentioned, the glomeruli of the kidney function to filter the blood and excrete 
waste products through the urine. Persistently high blood glucose levels cause damage to 
the blood vessels supplying the glomeruli, resulting in increased excretion of albumin 
(Lewis et al., 2015, p. 1182). Measuring albumin excretion can help to diagnose 
nephropathy even in pediatric patients. In fact, microalbuminuria, which is an albumin 
excretion rate of at least 30μg/mg of creatinine, is seen in 10 percent of pediatric patients 
with type II diabetes. This is especially concerning, since diabetic nephropathy can 
ultimately result in renal failure and end stage renal disease. Therefore, it is important 
that both pediatric and adult diabetic patients are monitored annually for their risk of this 
complication (Amutha & Mohan, 2016). 
 Diabetic neuropathy is a complication that affects most adult type II diabetes 
patients. It is a result of nerve damage, and can result in feelings of numbness or tingling, 
pain, loss of sensitivity, or even incontinence. (Lewis et al., 2015, pp. 1182-1183). While 
actual pediatric diabetic neuropathy is not common, many adolescents, between 20 and 
57 percent, have presented with a detectable decreased nerve threshold (Amutha & 
Mohan, 2016). Since it is common in the adult population and can develop over the 
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course of time, it is important for child and adolescent patients to be monitoring for 
symptoms of diabetic neuropathy. 
Macrovascular Complications 
 Macrovascular complications of type II diabetes involves larger blood vessels in 
the body, causing damage to areas such as the heart and brain. While actual cardiac 
events such as a myocardial infarction are rare in pediatric patients, type II diabetics 
present unique cardiac risks. Adolescents with type II diabetes have presented with left 
ventricular wall thickening, as well as increased signs of arterial stiffening. Arterial 
stiffening and development of atherosclerotic lesions, which are increased in pediatric 
diabetes patients, are precipitating factors to cardiovascular and cerebrovascular events 
later in life. Not much research is present regarding the mortality rates of pediatric 
patients with macrovascular complications. Therefore, it is recommended that pediatric 
patients follow current adult treatment recommendations to reduce complications, 
including controlling hypertension and dyslipidemia (Laffel & Svoren, 2017a). 
Causes 
 The pathophysiology, manifestations, diagnosis, and complications of pediatric 
type II diabetes have been discussed in detail. Having type II diabetes places child and 
adolescent patients at increased risk for possibly fatal complications, such as end stage 
kidney disease and stroke. Therefore, it is essential to study the cause behind the 
increasing number of pediatric patients that are being diagnosed with this disease. 
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Obesity 
 Most research currently links the increase of pediatric type II diabetes to pediatric 
obesity. Pediatric obesity is diagnosed using a body mass index (BMI) scale, which 
determines whether or not the child is at a healthy weight for their age and height. Using 
the patient’s height and weight, healthcare professionals calculate the child’s percentile, 
comparing them to other children with the same gender, height, and age. Children who 
are above the 95th percentile are considered to be obese. In recent years, childhood 
obesity has become a more common issue in the United States. According to the Centers 
for Disease Control and Prevention (CDC), the number of obesity cases “has more than 
tripled since the 1970s” (2017, para. 1). Most recent estimates in 2017 show that 1 in 5 
children aged 6-19 years old were classified as obese in the United States. This is a 
serious issue, because obesity can be linked to a high number of health risks, such as 
asthma, heart disease, and type II diabetes (Centers for Disease Control and Prevention, 
2017). 
 Pediatric obesity has been linked to insulin resistance. As previously mentioned, a 
major aspect of type II diabetes is insulin resistance. It decreases the effectiveness of 
insulin, and tissues throughout the body have more difficulty using blood glucose. This 
factor often causes the body to produce excess insulin, ultimately leading to beta cell 
exhaustion. One of the elements thought to contribute to insulin sensitivity is chronic 
inflammation from the release of adipokines. Adipokines are released from adipose tissue 
and aid in the metabolism of both glucose and fats (Lewis et al., 2015). In patients with 
obesity, increased adipose tissue has been linked to increase adipokine activity. This 
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increased activity, as well as the release of free fatty acids, are thought to contribute to 
increased insulin resistance in pediatric patients. Additionally, increased fat deposits in 
the abdomen have been linked to decreased insulin sensitivity (Marcovecchio, Mohn, & 
Chiarelli, 2010).  Overall, the increased amounts of fat that accompany pediatric obesity 
are thought to contribute to reduced insulin sensitivity, a precursor to type II diabetes. 
 In addition to insulin resistance, obesity can be linked to the development of 
metabolic syndrome. Metabolic syndrome is a condition in which a patient is diagnosed 
with at least three of the following five components: hypertension, elevated triglyceride 
levels, hyperglycemia, lowered high-density-lipoprotein (HDL) levels, and abdominal 
obesity. Patients with this group of abnormalities is thought to be at high risk for 
developing type II diabetes (Lewis et al., 2015, p. 1156). This group of conditions is 
fairly uncommon in pediatric patients. However, up to 50 percent of obese pediatric 
patients demonstrate metabolic syndrome, which is significantly linked to increased 
insulin resistance (Marcovecchio, Mohn, & Chiarelli, 2010). Ultimately, this places obese 
pediatric patients at even further risk of developing type II diabetes.  
 Poor Nutrition. In order to analyze pediatric obesity more closely, it is essential 
to acknowledge how obesity can develop. Obesity is usually considered a multifactorial 
issue. One of the more apparent factors contributing to pediatric obesity is poor diet and 
nutrition. An important component to a healthy diet is consumption of enough calories to 
meet metabolic demand. While exact caloric intake on any day may fluctuate, in general, 
a diet should not contain an abnormally high caloric excess, especially of foods that are 
not nutrient-dense. Eating caloric amounts excessively over what is needed can ultimately 
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contribute to gaining weight (Seth & Sharma, 2013). Additionally, high calorie diets also 
tend to include foods that are low in nutrients, high in sugars, and high in dietary fats. 
Regular consumption of these foods has been correlated with obesity development, 
especially between the age of 7 and 11, a time of growth for children (Emmett & Jones, 
2015). 
 Another dietary factor contributing to obesity is the popularity of “fast food”. 
Fast-food restaurants are becoming more available across the United States, and its use as 
a household meal supplement has increased significantly across the past few decades. 
Fast food conveniently allows food to be presented to its consumers quickly. However, 
the food served in fast food restaurants “tend to have high glycemic indexes, are often 
high in fats, and are sold in large portion sizes” (Alviola, Nayga, Thomsen, Danforth & 
Smartt, 2014, p. 111). This causes consumers to consume more calories than necessary, 
while consuming excess amounts of sugar. Additionally, fast food restaurants heavily 
advertise toward children in the media. These factors combined lead to more fast food 
consumption, ultimately leading to higher rates of childhood obesity (Alviola et al., 
2014). 
 Sedentary Lifestyle. Another factor contributing to the increase in childhood 
obesity is a sedentary lifestyle. Physical activity is an important aspect of staying healthy 
and avoiding weight gain. However, increased use of televisions and other electronic 
devices may be contributing to low levels of physical activity in pediatric patients. In a 
study of high school students, almost one third of participants were discovered to spend 
at least three hours daily playing video games. In that same group, nearly half did not 
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engage in the recommended hour of physical activity daily (Pulgaron & Delamater, 
2014). Ultimately, these studies show a tendency toward screen time over physical 
activity. Lacking proper physical activity and increase in sedentary behavior have been 
positively correlated with insulin resistance and development of childhood obesity 
(Pulgaron & Delamater, 2014). Moreover, studies have also shown that increased 
television watching is correlated with increased caloric intake (Seth & Sharma, 2013). 
Therefore, it is possible that a sedentary lifestyle may contribute to other risk factors of 
obesity development. Overall, lack of physical activity and increased sedentary lifestyle 
are additional factors contributing to the increasing obesity epidemic among the pediatric 
population, and ultimately, type II diabetes. 
Home Environment. The odds of a pediatric patient developing obesity can also 
be affected by the child’s home environment. Family is one of the largest influences in a 
child’s life, and can contribute to their overall health. While some exceptions exist, 
parents play a large role in what their children eat and do on a daily basis. Studies have 
shown that parental eating and behavioral habits play a role in the child’s risk of 
developing obesity, especially if they are obese themselves. In fact, studies have shown 
that if a child’s parents are obese, those children are more likely “to consume fatty foods, 
eat few vegetables, and engage in sedentary activities” (Alviola et al., 2014, p. 118).  As 
previously discussed, all of these factors can contribute to the onset of childhood obesity. 
Not only this, but there has also been positive correlation shown between parental BMIs 
and their children’s BMIs (Pulgaron & Delamater, 2014). Therefore, parental obesity 
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status can play a large role in determining whether or not their children will also become 
obese.  
Schools. In addition to family, school is an important influence in a child’s 
overall health and nutrition. Statistics show that 35 to 47 percent of a child’s calories are 
being consumed while in the school environment (Cluss, Fee, Culyba, Bhat, & Owen, 
2014). Schools can directly have an impact on children buying school lunches, especially 
if unhealthy food options are being provided. Furthermore, studies have linked higher 
rates of obesity when schools are located closer to fast food restaurants (Alviola et al., 
2014). Therefore, where the school is located can also play a role in obesity rates. This is 
especially true for schools located in areas of low socioeconomic status. One study found 
that schools of low socioeconomic status were less likely to have funding for physical 
education teachers (Carlson et al., 2014). Additionally, these schools less likely to 
provide adequate physical education classes than their high socioeconomic counterparts 
(Pulgaron & Delamater, 2014). Overall, schools play a large role in determining a child’s 
risk for obesity. 
Lower Income Communities. Lastly, one population of children that are 
particularly affected by obesity are those in lower income communities, especially ethnic 
minority children. Minority children are more likely to live in lower-income 
neighborhoods, which often do not provide a safe environment to play outside. Without 
sidewalks and safe areas to be physically active, these children risk living a more 
sedentary lifestyle, which increases their risk for obesity and type II diabetes (Pulgaron & 
Delamater, 2014). Furthermore, children in lower income communities tend to have less 
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access to affordable, healthy foods from supermarkets. Lower income communities, on 
average, have more access to fast food restaurants, which tends to be cheaper than 
healthy alternatives. Even with access to supermarkets, healthy food alternatives can still 
be more expensive. In fact, in a study discussed by Alvioli et al., increases in healthy 
food prices have been linked to an increased risk for childhood obesity (2014). Therefore, 
the affordability of food may be another cause to consider in the rise of childhood 
obesity.  
Ultimately, childhood obesity is one of the most common links found to explain 
the increase of pediatric type II diabetes cases. In fact, Pulgaron and Delamater discuss 
that “over 85% of children with T2D are either overweight or obese at diagnosis” (2014, 
p. 508). This is a staggering statistic, showing the positive link between the two. 
However, there are other factors that could be contributing to this crisis, such as 
developmental overnutrition. 
Developmental Overnutrition 
 Developmental overnutrition is a theory proposed by many researchers, theorizing 
that having diabetes during pregnancy increases the risk of the child having diabetes later 
in life. Different studies have shown fetuses exposed to the hyperglycemia of a diabetic 
mother are at greater risk for developing metabolic syndrome, obesity, and type II 
diabetes later in life. The Pima Indian study even compared siblings before and after the 
mother’s diagnosis of diabetes. The results of the study showed that siblings born after 
the diagnosis had a three times greater risk of developing type II diabetes. Therefore, 
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there seems to be a definite correlation between maternal diabetes and childhood 
development of type II diabetes (Dabelea & Harrod, 2014). 
 Maternal utilization of glucose during pregnancy plays a large role in 
developmental overnutrition. During a normal pregnancy, insulin sensitivity is naturally 
decreased as nutrients are pulled from the mother’s bloodstream by the placenta. This 
allows the placenta to provide more nutrients to the baby, and can be related to a number 
of hormonal factors. By the third trimester, a woman’s insulin sensitivity may even 
decrease by 50 percent (Sonagra, Biradar, K., & Murthy, 2014). However, women with 
type II diabetes have decreased insulin sensitivity even before the onset of pregnancy. 
Women with type II diabetes during pregnancy utilize glucose differently than 
nondiabetic women. The insulin resistance that accompanies type II diabetes causes 
hyperglycemia, therefore increasing the amount of glucose available in the bloodstream. 
This excessive amount of glucose is brought to the fetus, causing the developing pancreas 
to secrete insulin. Exposure of the fetus to excessive amounts of insulin can cause 
increased growth, which has been linked to increased risk of obesity and type II diabetes 
later in life. Maternal diabetes and obesity were estimated to play a role in 47.2% of the 
pediatric type II diabetics in the SEARCH case-control study (Dabelea & Harrod, 2014). 
Therefore, maternal glucose levels and how they are utilized during pregnancy can 
impact the fetus’s risk of long term complications. 
 With cases of type II diabetes on the rise, it is important to note that 
developmental overnutrition could definitely play a role in increasing pediatric cases. 
Developmental overnutrition views the risks of type II diabetes from the perspective of 
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the fetus’s environment. However, a baby’s chance of developing type II diabetes can 
also be affected by their family history.  
Family History 
 One risk factor that seems to increase the risk of pediatric type II diabetes is a 
family history of the disease. While lifestyle changes are often causative factors, genetics 
can also determine whether or not a child is predisposed. Almost 75 percent of pediatric 
patients with type II diabetes have a parent that is affected by the disease (Laffel & 
Svoren, 2017a). Additionally, twin studies have shown that “in monozygotic twins with 
one affected twin, the other twin has a 90 percent chance of developing diabetes” (Laffel 
& Svoren, 2017a, para. 15). This evidence shows that a familial link does appear to exist 
between relatives with type II diabetes. With type II diabetes also on the rise in adults, 
this link would most likely contribute to increases in pediatric cases. However, definitive 
genetic proof for this link has not yet been determined. Over 150 variations of DNA are 
been discovered that can be associated with the risk of type II diabetes. Some are 
theorized to play a role in developing the pathophysiology behind the disease, such as 
beta cell dysfunction. However, some of these genes are present in patients without type 
II diabetes, and no specific inheritance pattern has been discovered (U.S. National 
Library of Medicine, 2018). Therefore, having specifics genes may increase a child’s risk 
for developing type II diabetes, but it is unlikely that this factor alone directly causes the 
disease.  
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Other Factors  
 Stress. Another interesting approach to the development of pediatric type II 
diabetes is the involvement of psychological factors, such as stress. While it is noted that 
pediatric patients with diabetes tend to have poor diets and decreased physical activity, 
another factor that tends to be common amongst them is high stress levels (Nadeau et al., 
2016).  When experiencing stress, the body initiates the fight or flight response from the 
sympathetic nervous system. This causes various responses throughout the body that 
could aid in an emergency situation. This includes improved cardiac output, increased 
blood pressure, and increased blood glucose levels. In order to increase blood glucose 
levels, the hypothalamus within the brain releases corticotropin-releasing hormone 
(CRH). CRH initiates the release of adrenocorticotropic hormone from the pituitary 
gland, which stimulates the adrenal cortex to allow for the release of cortisol. For short 
periods of time, cortisol can be helpful in decreasing inflammation, aiding the work of 
other hormones, and increasing blood glucose for energy utilization (Lewis et al., 2015, 
p. 90). However, having prolonged, high levels of blood glucose is not beneficial for the 
body, as seen with type II diabetes complications.   
 While the stress response is often related to emergent physical situations, mental 
stress can also cause it to initiate. In adults, mental stress has been linked to increased 
glucose levels, especially in type II diabetes patients (American Diabetes Association, 
2013). However, adults are not the only ones to experience stress. With the development 
of higher academic standards and expectations for high school students, adolescents may 
be at increased risk for mental stress. One exploratory study found that nearly half of high 
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school students in a test group reported having a “great deal of stress on a daily basis” 
(Leonard et al., 2015, p. 5). Other research has shown that children in situations of high 
family stress, such as single parent homes, were found to be more overweight than 
children from low stress households (Pulgaron & Delamater, 2014). Additionally, studies 
have shown how “chronic exposure to social and environmental stressors negatively 
impact body weight, metabolism, blood pressure, and the sympathetic nervous system” 
(Nadeau et al., 2016, p. 1637). These factors could play a large role in the development of 
prolonged hyperglycemia and metabolic syndrome. As previously mentioned, prolonged 
hyperglycemia can ultimately lead to beta cell dysfunction, contributing to type II 
diabetes. Therefore, mental stress in pediatric patients, particularly adolescents, may 
contribute to the development of type II diabetes. 
 Sleep. Sleep is another factor that could contribute to type II diabetes. Abnormal 
sleeping patterns have been considered a risk factor in pediatric patients in decreasing 
insulin sensitivity with puberty (Nadeau et al., 2016). In a longitudinal study examining 
children’s sleep quality from infancy to mid-childhood, it was found that over time, 
insufficient sleeping patterns could contribute to poor diet quality. Ultimately, the results 
showed that this poor diet quality could be contributing to childhood obesity (Cespedes et 
al., 2016). Poor diet quality, increased adipose tissue and childhood obesity have all been 
linked to the development of type II diabetes in pediatric patients, according to research 
stated throughout this paper. Therefore, while more research may be needed, it is possible 
that lack of proper sleep could be contributing to the type II diabetes crisis among 
pediatric patients.  
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Treatment 
As the pediatric population with type II diabetes soars, healthcare professionals 
need to provide proper treatment. One of the largest problems in regard to type II diabetes 
is prolonged hyperglycemia. Since most of these patients still have some insulin 
production, some treatment methods may not involve the use of medications.  
Diet Changes 
Adults with this disease are usually encouraged to treat the condition with proper 
diet control. Diabetic diets focus on eating healthy foods that have a low glycemic index. 
A glycemic index indicates how quickly a food will raise the patient’s blood sugar (Mayo 
Clinic Staff, 2018). Certain foods, such as many fruits and vegetables, have a low 
glycemic index, while other foods, such as candy, may have a high glycemic index. By 
consuming certain foods and monitoring carbohydrate intake, diabetic patients can help 
themselves to maintain a more normal blood glucose level (Mayo Clinic Staff, 2018). In 
pediatric patients, diet changes are just as important. Especially since childhood obesity is 
associated with higher levels of insulin resistance, it is essential for these patients to 
exercise portion control and eliminate many unhealthy foods from their diets. Eating as a 
family and avoiding snacking while using electronics can help to eliminate excessive 
food and drink intake. Instead, healthy snacks and portioned meals, with less saturated 
fats and sugars, should be eaten throughout the day (Samaan, 2013). Ultimately, this will 
help pediatric patients to lose weight and manage their blood glucose levels. 
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Physical Activity 
  Another intervention commonly used to control type II diabetes is the use of 
physical exercise. As previously discussed, both diet and lack of physical exercise can 
play a role in the development of pediatric type II diabetes. Physical activity is a helpful 
tool in treating type II diabetes since it can improve insulin sensitivity (Laffel & Svoren, 
2017b). By improving insulin sensitivity, more glucose can be absorbed and used for 
energy by the body, instead of accumulating in the bloodstream. Pediatric patients are 
encourage to participate in “moderate to vigorous physical activity for at least one hour 
daily” (Laffel & Svoren, 2017b, para. 17). Participating in this physical activity can also 
help to improve mood and reduce stress levels (Samaan, 2013). As previously discussed, 
many pediatric patients have increased stress, leading to the release of excess glucose. 
Therefore, by reducing stress and improving insulin sensitivity, physical activity could 
improve blood glucose control for some patients.  
Weight Control 
 Ultimately, using diet changes and physical activity can help pediatric patient 
with weight control. Childhood obesity has already been linked to increased insulin 
resistance and the development of pediatric type II diabetes. Contrastingly, weight loss in 
these obese patients has been shown to improve symptoms of type II diabetes. In 
pediatric patients specifically, reductions in BMI have been shown to produce low 
hemoglobin A1C results, increased insulin sensitivity, and reduced need for medications. 
While the specific goals of weight loss or maintenance depend on the individual patient, 
the general goal for all of these patients is to be below the 85th percentile for BMI. While 
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diet and physical activity may been adequate for some patients, some studies have shown 
the effects of gastric bypass surgery on obese adolescents. While little research is 
available, some research shows that it could be correlated with weight loss and remission 
of type II diabetes in these patients. However, more research must be conducted to 
conclude whether or not this is an appropriate interventions for other pediatric patients 
(Laffel & Svoren, 2017b).  
Medications 
 Insulin. While other interventions may be helpful in controlling type II diabetes, 
some patients often require the use of medications to control their glucose levels. 
Synthetic insulin is a commonly used medication among both the adult and pediatric type 
II diabetes population. Due to either insulin resistance or decreased insulin production, 
type II diabetes patients often require extra insulin to bring blood glucose levels within a 
normal range (Laffel & Svoren, 2017b). Several types of insulin exist, including short-
acting and long-acting varieties. Each type of insulin is differentiated by time of onset, 
peak, and duration. Longer acting versions, such as insulin glargine, can be used to 
control blood glucose levels over the course of a day. However, other formulations, such 
as insulin lispro, are commonly used with meals and can be adjusted based on the specific 
dietary intake. Ultimately, healthcare providers may use one or a combination of different 
insulins in order to regulate a patient’s glucose levels (Burchum et al., 2016, pp. 676-
679). 
 While using any form of insulin, it is important for patients to monitor their own 
glucose levels. Due to the nature of diabetes and its treatment, type II diabetics are at risk 
PEDIATRIC TYPE II DIABETES MELLITUS 
 
27 
for both hypoglycemia and hyperglycemia. Blood glucose levels could fluctuate 
depending on the amount of insulin given, whether it was too much or too little. 
Therefore, it is important for patients to monitor their blood glucose levels while self-
administering treatment at home with the use of glucometers. By using a drop of blood, 
these machines can enable patients to discover their current blood glucose level. The 
frequency of taking these levels can range from multiple times a day to once a week 
depending on individualized treatment. Common times for measurement include before 
meals and at bedtime with shorter-acting insulins. Generally, blood glucose levels should 
fall between 70 and 130 mg/d prior to meals and 100 to 140 mg/dL before bedtime. 
Knowing these exact blood glucose levels can help patients to adjust their insulin dosage 
according to their healthcare provider’s instructions (Burchum et al., 2016, pp. 673-674). 
 Metformin. While insulin is an essential part of some medication regiments, the 
first line medication for pediatric patients with type II diabetes is actually metformin 
(Samaan, 2013). Metformin is an oral medication that helps to decrease blood glucose 
levels by inhibiting gluconeogenesis in the liver and increasing insulin sensitivity 
(Skidmore-Roth, 2016, p. 746). This allows tissues throughout the body to more easily 
use naturally produced insulin, while disrupting the overcompensation mechanisms from 
the liver. In pediatric patients, metformin has been shown to provide decreased 
hemoglobin A1C levels and body weight (Samaan, 2013). In general, this drug is used by 
many adolescents initially with type II diabetes diagnosis, along with diet control and 
physical exercise. While it can be used alone, metformin can also be used with other 
drugs, such as insulin, to maintain adequate glucose levels in type II diabetic patients 
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(Burchum et al., 2016, p. 684). Ultimately, use of this drug in adolescents should provide 
an initial blood glucose reduction, and should maintain adequate levels in almost half of 
patients (Laffel & Svoren, 2017b). Therefore, unless contraindicated, metformin is 
considered a cornerstone of treatment of pediatric type II diabetes patients.   
Other medications. Additional hypoglycemic medications can be added to an 
adult regimen, including sulfonylureas, thiazolidinediones and incretin mimetics, which 
all work to lower glucose levels. These treatments have been primarily researched for 
effectiveness only in adult patients (Samaan, 2013). Some of these drugs, such as 
glimepride, have been studied in the pediatric population and have been shown to be 
effective in lowering hemoglobin A1C levels. However, use of drugs other than 
metformin and insulin have not yet been approved by the U.S. Food and Drug 
Administration (FDA) for use in the pediatric population (Laffel & Svoren, 2017b). 
Therefore, while these drugs may provide alternative treatment options to these patients, 
further research must be conducted in order to ensure their safety with use in children.  
Compliance 
One of the biggest obstacles facing this epidemic is lack of treatment compliance, 
both in the pediatric and adult populations. Due to their age, pediatric patients with type 
II diabetes may be at a specific disadvantage for adhering to treatments. Parents and other 
family members often still play a large role in lifestyle choices, which has an impact on 
possible dietary changes, improvement in physical activity, or medication adherence. 
Therefore, it is important to include the family in education and treatment plans (Reinehr, 
2013). However, when diagnosed, adolescents tend to have more autonomy over their 
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actions, and often experience a cognitive disconnect between their disease and long-term 
outcomes.  Lack of compliance can also occur due to inconvenience and fear of peer 
rejection. Therefore, it is important that in these cases, healthcare workers recognize 
these extra difficulties in treatment compliance when treating pediatric patients with this 
disease (Pulgaron & Delamater, 2014). 
 In addition to involving the family in care, treatment compliance can be improved 
by individualizing treatment plans. One area that can be individualized in pediatric 
patients are dietary changes. Every child has a different palette, preferring certain foods 
over others. Therefore, dietary changes and education should be implemented based on 
each child’s specific dietary habits. This may include reducing fast food intake, replacing 
foods with healthier alternatives, and decreasing portion sizes of foods already consumed. 
It should be a priority to set realistic goals with both the pediatric patient and their family. 
Otherwise, it may be difficult for compliance in the long-term setting (Laffel & Svoren, 
2017b).  
An additional area to improve treatment compliance is physical activity. As 
previously discussed, recommendations show that children and adolescents should be 
getting about 60 minutes of physical activity daily. However, for a patient with a 
generally sedentary lifestyle, this may be a difficult change. One intervention that may be 
helpful in improving compliance is flexibility. All 60 minutes of physical exercise do not 
have to be performed in one sitting. Instead, this activity can be spread throughout the 
day, including activities such as climbing stairs and taking walks. By providing flexibility 
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and allowing the patient to do activities they prefer, treatment compliance for physical 
activity may be improved (Samaan, 2013).  
Lastly, medication adherence is another important aspect of type II diabetes 
management. Taking medications properly can help to manage blood glucose levels and 
prevent some complications. However, routinely monitoring blood glucose and injecting 
insulin may prove to be inconvenient and embarrassing for pediatric patients (Pulgaron & 
Delamater, 2014). Therefore, the use of oral medications, such as metformin, are 
correlated with higher rates of compliance in pediatric patients (Reinehr, 2013). 
Therefore, use of oral agents, such as metformin, are routinely given over injectable 
agents such as insulin when possible. 
Clinical Outcomes 
 Ultimately, this increasing epidemic is taking a large toll on the pediatric 
population. Having type II diabetes can take a toll on pediatric bodies throughout the rest 
of their life. Being diagnosed in childhood places pediatric patients at a higher risk for 
developing microvascular and macrovascular complications in adulthood (Amutha & 
Mohan, 2016). This can include cardiovascular disease and diabetic nephropathy, each 
serious conditions that could ultimately result in death. In fact, it is estimated that 
pediatric patients with type II diabetes are expected to live 15 years less than those 
without type II diabetes (Pulgaron & Delamater, 2014). Furthermore, pediatric patients 
may be at risk for higher levels of psychological problems. In a study addressed by 
Pulgaron & Delamater, up to 20 percent of pediatric patients with type II diabetes 
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reported feeling depressed (2014). Overall, having type II diabetes in a younger 
population is showing reduced physical and psychological outcomes for patients. 
Conclusion 
In conclusion, the growth of type II diabetes in pediatric patients is still being 
studied. This area of research is still relatively new as compared to adult research, since 
as previously discussed, this disease used to primarily have onset in adulthood. Now, 
both children and adolescents are at a greater risk for acquiring this disease. With an 
earlier onset, pediatric patients are at great risk for a variety of complications, both 
physical and psychological. Current research points to obesity as the main cause of this 
epidemic, but other factors, such as developmental overnutrition and family history, may 
also play a role. While treatment options exist, more research must be done in regard to 
finding effective ways to both prevent and manage this disease. Hopefully, by 
recognizing these possible causes, new measures can be developed to ultimately improve 
patient’s lives and outcomes.  
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